BIOMAT Database Logo BIOMAT Database Logo

Bezafibrate does not influence the QT interval in man. 1983

A G Olsson, and L G Ekelund, and P D Lang, and J Vollmar

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D002995 Clofibric Acid An antilipemic agent that is the biologically active metabolite of CLOFIBRATE. Clofibrinic Acid,2-(4-Chlorophenoxy)-2-methylpropionic Acid,NSC-1149,p-Chlorophenoxyisobutyrate,p-Chlorophenoxyisobutyric Acid,NSC 1149,NSC1149
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000960 Hypolipidemic Agents Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. Antihyperlipidemic,Antilipemic,Antilipemic Agents,Antilipemic Drug,Hypolipidemic Agent,Hypolipidemic Drug,Antihyperlipemics,Antihyperlipidemics,Antilipemic Drugs,Antilipemics,Hypolipidemic Drugs,Agent, Hypolipidemic,Agents, Antilipemic,Agents, Hypolipidemic,Drug, Antilipemic,Drug, Hypolipidemic,Drugs, Antilipemic,Drugs, Hypolipidemic

Related Publications

A G Olsson, and L G Ekelund, and P D Lang, and J Vollmar
Abemaciclib does not increase the corrected QT interval in healthy participants.
September 2023, Clinical and translational science,
A G Olsson, and L G Ekelund, and P D Lang, and J Vollmar
Single-dose ticagrelor does not prolong the QT interval in healthy subjects.
October 2010, International journal of clinical pharmacology and therapeutics,
A G Olsson, and L G Ekelund, and P D Lang, and J Vollmar
AZD8233 antisense oligonucleotide targeting PCSK9 does not prolong QT interval.
November 2022, British journal of clinical pharmacology,
A G Olsson, and L G Ekelund, and P D Lang, and J Vollmar
Does infection prolong the QT interval?
September 2020, Internal medicine journal,
A G Olsson, and L G Ekelund, and P D Lang, and J Vollmar
Dabigatran does not prolong the QT interval with supratherapeutic exposure: a thorough QT study in healthy subjects.
May 2013, Clinical drug investigation,
A G Olsson, and L G Ekelund, and P D Lang, and J Vollmar
Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study.
December 2017, Cancer chemotherapy and pharmacology,
A G Olsson, and L G Ekelund, and P D Lang, and J Vollmar
Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study.
November 2007, European journal of clinical pharmacology,
A G Olsson, and L G Ekelund, and P D Lang, and J Vollmar
Moxifloxacin does increase the corrected QT interval.
October 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
A G Olsson, and L G Ekelund, and P D Lang, and J Vollmar
The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study.
April 2013, Cardiovascular diabetology,
A G Olsson, and L G Ekelund, and P D Lang, and J Vollmar
Clofazimine does not lead to significant QT interval prolongation: a multicentre study.
November 2018, The European respiratory journal,
Copied contents to your clipboard!